Search results
Results from the WOW.Com Content Network
However, it is acceptable to screen this age group with a Pap smear alone every 3 years or with an FDA-approved primary high risk HPV test every 5 years. [11] In women over the age of 65, screening for cervical cancer may be discontinued in the absence of abnormal screening results within the prior 10 years and no history of high-grade lesions ...
However, “a good rule of thumb is that women ages 21-29 should get a pap test every three years [and] women older than that continue getting paps every three years or choose to space out testing ...
Pap tests should be done every three years between the ages of 21 and 65. [83] In women over the age of 65, screening may be discontinued if no abnormal screening results were seen within the previous 10 years and no history of CIN2 or higher exists. [83] [84] [85] HPV vaccination status does not change screening rates. [84]
Because of the link between HPV and cervical cancer, the ACS currently recommends early detection of cervical cancer in average-risk asymptomatic adults primarily with cervical cytology by Pap smear, regardless of HPV vaccination status. Women aged 30–65 should preferably be tested every 5 years with both the HPV test and the Pap test.
The American Cancer Society's updated cervical cancer screening requirements now suggest that people with a cervix undergo human papillomavirus virus (HPV) primary testing — instead of a Pap ...
For premium support please call: 800-290-4726 more ways to reach us
Screening is recommended for women over 21 years, initially women between 21 and 29 years old are encouraged to receive Pap smear screens every three years, and those over 29 every five years. [2] For women older than the age of 65 and with no history of cervical cancer or abnormality, and with an appropriate precedence of negative Pap test ...
Pap tests can usually be performed during pregnancy up to at least 24 weeks of gestational age. [34] Pap tests during pregnancy have not been associated with increased risk of miscarriage. [34] An inflammatory component is commonly seen on Pap smears from pregnant women [35] and does not appear to be a risk for subsequent preterm birth. [36]